A pilot study is underway to see how mobile technology can be used to improve diabetes care in adults with Type 1 diabetes. The REMOTE-T1D (NCT01825382) study is sponsored by the University of Colorado, Denver School of Medicine in the Barbara Davis Center along with collaborators Sanofi, and the Colorado Prevention Center.
The Principal Investigator Satish K. Garg MD reports that the goal is to evaluate the use of remote technology such as iBGStar in combination with Diabetes Manager App on the iPhone in terms of patient related outcomes and satisfaction with the treatment. There may be possible reductions of glucose excursions, A1C, and severe hypoglycemia as compared to routine clinical care using the traditional glucose meter SMBG-Accu-chek. The study aims to demonstrate the efficacy of these technologies in a clinical setting with the hope to improve outcomes and achieve healthcare cost savings.
In the future, this study might lead to investigating the role of social media used with mobile phones for Type 1 Diabetes care. As the number of patients with Type1Diabetes continues to increase, the use of this technology could possibly help compensate for the shortage of endocrinologists available to provide care.
The study started December 2012 and the completion date is scheduled to be November 2013. The study enrolled 100 patients from the Barbara Davis Center Adult Clinic over the age of 18, and the study will be randomized to an intervention group using mobile technology (iBGStar) versus continued routine clinical care using SMBG-Acc-chek meter. Subjects will be followed frequently and will wear a continuous glucose monitor using a DexCom SEVEN Plus system for 7 days.
For more information, go to http://clinicaltrials.gov/ct2/show/NCT01825382.
Montana’s public health services are delivered primarily through contracts with local and tribal public health agencies in every county and reservation in the state as well as to private providers, clinics, hospitals, and other organizations. The Public Health and Safety Division (PHSD) leads the state’s public health efforts and provides state-level coordination of key public health services to local and tribal public health agencies. (more…)
Honeywell HomMed is featuring new case studies highlighting effective strategies for implementing telehealth programs. Each case study examines the challenges home healthcare agencies face and how telehealth solutions using patient monitoring services can work to improve outcomes. (more…)
A new state-of-the-art facility dedicated to pediatric cardiac imaging and intervention is going to be co-established by NIH and Children’s National Medical Center in Washington D.C. The Center will combine cardiac imaging expertise at NIH’s National Heart, Lung, and Blood Institute (NHLBI) with clinical care at Children’s hospital. (more…)
The National Indian Health Board (NIHB) Regional Extension Center (REC) is entering its final project year as reported in the April 2013 Indian Health Service Office of Information Technology Newsletter. To date, the NIHB REC has signed up 3,036 Primary Care Providers working in Indian Health System facilities to receive REC health IT services. (more…)
As America’s population ages demand for high quality hospice care is growing. As a result, innovative providers are searching for new services that add to the well-being, comfort, and peace of mind of patients and families.
The Hospice of the Western Reserve, a non-profit hospice organization is providing care and support throughout Northern Ohio by using telyHD™ video calling devices installed in 42 patient rooms at their residential care facility called the Ames Family Hospice House. (more…)
Researchers at Lawrence Livermore National Laboratory (LLNL) have developed their Microbial Detection Array (LLMDA) technology to detect bacteria, viruses, and other organisms.
Emerging known and unknown pathogens create threats to public health so the ability to rapidly detect and characterize microbial agents is critically needed to prevent and respond to disease outbreaks. This technology can also be used to help determine the safety of products, useful for molecular diagnostics, homeland security, and for forensics.
Existing detection technologies are based on nucleic acid amplification of sequences from one or a small set of organisms. While they are able to rapidly identify selected pathogens at the species or strain level, they can’t be multiplexed to the degree required to detect hundreds to thousands of different organisms.
The laboratory has developed the probes for the microarray and the software to analyze the microarray data and now LLNL is looking for partners to license as well as partners to develop additional capabilities.
For more information on ID 22110, email Ida Shum at email@example.com.